Title:
少なくとも1種の糖含有阻害性物質の用途
Document Type and Number:
Japanese Patent JP2005504017
Kind Code:
A
Abstract:
The present invention relates to the use of a glycosidase inhibitor for the manufacture of a medicament for the treatment of a disease, wherein glycosidase enzymes hydrolyze glycoconjugates of a patient to reveal neutral glycan receptors of an pathogenic agent, and wherein the revealed neutral glycan receptor comprise a oligosaccharide sequence.
Inventors:
Natunen, Spear
Mirror-Pola The, Halina
Teneveli, Susan
Angstrom, Jonas
Carlson, Karl-Andes
Mirror-Pola The, Halina
Teneveli, Susan
Angstrom, Jonas
Carlson, Karl-Andes
Application Number:
JP2003508366A
Publication Date:
February 10, 2005
Filing Date:
June 28, 2002
Export Citation:
Assignee:
Bioty Therapy Corps
International Classes:
A23L1/30; A23L3/3562; A61K8/00; A61K8/60; A61K8/73; A61K31/702; A61K31/7028; A61K31/739; A61P1/02; A61P1/04; A61P1/16; A61P1/18; A61P3/02; A61P9/00; A61P11/00; A61P17/00; A61P31/04; A61P31/10; A61P31/12; A61P31/16; A61P35/00; A61P43/00; A61Q11/00; A61Q19/10; C07H7/027; C07H15/10; C12N9/99; (IPC1-7): A61K31/702; A23L1/30; A23L3/3562; A61K7/00; A61K7/16; A61K7/50; A61K31/7028; A61P1/02; A61P1/04; A61P1/16; A61P1/18; A61P3/02; A61P9/00; A61P11/00; A61P17/00; A61P31/04; A61P31/10; A61P31/12; A61P31/16; A61P35/00; A61P43/00; C12N9/99
Attorney, Agent or Firm:
Junzo Watanabe